Prevalence and risk factors for nosocomial lower respiratory tract infections in German hospitals

Journal of Clinical Epidemiology
G KampfF Daschner

Abstract

The prevalence and risk factors for nosocomial lower respiratory tract infections (LRTI) in Germany were determined as part of a national survey on nosocomial infections. The study included 14,966 patients in 72 representatively selected hospitals with departments of general medicine, surgery, obstetrics, gynecology, and intensive care units (ICU). Surveillance was carried out by four previously validated medical doctors who strictly applied the CDC-criteria for diagnosis of nosocomial infections. The overall prevalence of hospital-acquired LRTI was 0.72% with the highest rate in hospitals with more than 600 beds (1.08%) and among the patients on intensive care units (9.00%). Ventilator-associated pneumonia rates were highest in patients on ICUs (13.27). Polytrauma, impaired consciousness, chronic airway disease, prior surgery, and cardiovascular disease were significantly related to the occurrence of nosocomial LRTI. P. aeruginosa was the predominant organism causing nosocomial LRTI. Nosocomial LRTI remain a problem mainly on ICUs. Patients at risk should be monitored with extra care.

References

Jun 1, 1992·European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology·I KappsteinF D Daschner
Sep 16, 1991·The American Journal of Medicine·D E CravenT W Barber
Dec 7, 1990·Deutsche medizinische Wochenschrift·W Habscheid
Jan 1, 1989·European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology·S L Berk, A Verghese
Jan 1, 1989·European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology·R P Wenzel
Sep 1, 1989·Statistics in Medicine·R J Carroll
Jun 1, 1988·American Journal of Infection Control·J S GarnerJ M Hughes
Jul 1, 1986·The Journal of Hospital Infection·M L MoroA Zampieri
May 1, 1988·The Journal of Hospital Infection·H SrámováV Subertová
May 1, 1986·Archives of Internal Medicine·J G BartlettS L Gorbach
Sep 1, 1980·The Journal of Hospital Infection·O B Jepsen, N Mortensen
May 15, 1984·The American Journal of Medicine·F S RhameP B McGlave
Aug 1, 1984·American Journal of Infection Control·C P Craig, S Connelly
Mar 1, 1981·The American Journal of Medicine·R A GaribaldiN L Pace
Feb 1, 1980·The American Journal of Medicine·P A GrossN Aswapokee
Aug 1, 1995·Chest·C S Garrard, C D A'Court
Dec 1, 1993·American Journal of Infection Control·S I KelleghanL Becker
May 1, 1993·Antimicrobial Agents and Chemotherapy·D H Hamer, M Barza
Jun 1, 1996·American Journal of Surgery·T S HellingA Stewart
Mar 1, 1996·The Journal of Hospital Infection·A M EmmersonE T Smyth
Mar 26, 1998·The Journal of Hospital Infection·P GastmeierH Rüden

❮ Previous
Next ❯

Citations

Nov 24, 2004·European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology·D P KofteridisA Gikas
Jun 24, 2003·The Journal of Hospital Infection·A LizioliV Carreri
Aug 5, 1999·Letters in Applied Microbiology·S StampiG De Luca
May 5, 2011·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Pranita D TammaSara E Cosgrove
Mar 14, 2001·Critical Care Medicine·A Tejada ArtigasA Hernández
Oct 19, 2004·Clinical Microbiology Reviews·Günter Kampf, Axel Kramer
Aug 27, 2011·Clinics in Chest Medicine·Lucy B Palmer
Jan 26, 2007·International Journal of Dental Hygiene·A S Al-HiyasatY S Khader
May 7, 2014·Infection Control and Hospital Epidemiology : the Official Journal of the Society of Hospital Epidemiologists of America·Walter ZinggDidier Pittet
Mar 1, 2005·Microbes and Infection·Manuela CavalcantiAntoni Torres
Oct 31, 2002·JPEN. Journal of Parenteral and Enteral Nutrition·Norma A Metheny
Dec 8, 2006·Dermatitis : Contact, Atopic, Occupational, Drug·Lauren Campbell, Matthew J Zirwas
Mar 12, 2009·Current Opinion in Infectious Diseases·Saad NseirCharles-Hugo Marquette
May 8, 2020·BMC Medical Research Methodology·Scott A McDonaldBrecht Devleesschauwer

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.